Tarek Helmy, MD
Interventional Cardiology · Shreveport, LANPI 1851306641
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (50.6%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Medtronic accounts for 60.3% of it on its own, with 31 other manufacturers making up the rest. Reporting peaked in 2024 at $15,324 and has fallen 93.8% since, to $947 in 2025.
Across 343 payments — averaging $132.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$27K
- Boston Scientific$5K
- Abiomed$4K
- Edwards Lifesciences$2K
- Corindus Inc.$2K
- Abbott$2K
- plus $3K from 26 others
Across 57 payments — averaging $2233.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cardiovascular Systems Inc.$90K
- Amgen$32K
- Abbott$5K
What the payments were for
- Speaking & faculty fees$23,06351%
- Travel & lodging$11,48525%
- Food & beverage$10,99324%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 64 | $27,461 |
| Boston Scientific | 32 | $5,012 |
| Abiomed | 96 | $3,787 |
| Edwards Lifesciences | 14 | $2,378 |
| Corindus Inc. | 6 | $1,840 |
| Abbott | 19 | $1,822 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 53 | $1,005 |
| Penumbra, Inc. | 3 | $414 |
| Pfizer | 5 | $257 |
| Cardiovascular Systems Inc. | 7 | $205 |
| Cardiva Medical, Inc. | 5 | $183 |
| Impulse Dynamics (USA) Inc. | 1 | $169 |
| Shockwave Medical, Inc | 4 | $133 |
| Lundbeck LLC | 1 | $113 |
| Philips North America LLC | 1 | $105 |
| E.r. Squibb & Sons, L.L.C. | 7 | $102 |
| Merck | 3 | $94 |
| Amgen | 2 | $54 |
| AstraZeneca(2 entities) | 3 | $49 |
| Johnson & Johnson | 3 | $46 |
| Kestra Medical Technology Services, Inc. | 2 | $45 |
| Heartflow, Inc. | 1 | $40 |
| Siemens Medical Solutions USA, Inc. | 1 | $35 |
| Boehringer Ingelheim | 2 | $32 |
| Daiichi Sankyo Inc. | 1 | $29 |
| ZOLL Circulation Inc | 1 | $25 |
| Novo Nordisk | 1 | $22 |
| Lexicon Pharmaceuticals, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Scpharmaceuticals Inc. | 1 | $18 |
| Lantheus Medical Imaging, Inc. | 1 | $14 |
| Bard Peripheral Vascular, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- COREVALVE EVOLUT R$25,587
- VersaCross Access Solution$2,340
- Impella$2,104
- Edwards SAPIEN 3 Transcatheter Heart Valve$2,096
- CorPath GRX$1,710
- MitraClip$810
- OPTIMIZER$337
- Tendyne Mitral Valve System$311
- CoreValve Evolut$293
- Indigo System$264
- Mitra Clip system$252
- Resolute$249
- Indigo$150
- LifeVest$126
- Coronary Orbital Atherectomy System$125
- LOTUS EDGE$123
- VYNDAQEL$114
- NORTHERA$113
- WATCHMAN Access System$106
- IGT D Coronary$105
How this compares
$45,540 in reported general payments places this provider in the 80th percentile of 171 interventional cardiology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 20 | $148 |
| Atorvastatin Calcium | 17 | $69 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Shreveport
- Steven BaileyShreveport$305K
- James SmithShreveport$31K
- Eric ReevesShreveport$27K
- Boshra LoukaShreveport$23K
- Pavan KatikaneniShreveport$20K
- George MinaShreveport$19K
- Paul DavisShreveport$16K
- Craig WalkerHouma$5M
- Denzil MoraesBaton Rouge$901K
- Ankur LodhaLafayette$640K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.